Quantitative PET cerebral glucose metabolism estimates using a single non-arterialized venous-blood sample

Annals of Nuclear Medicine

Volumn 18, Issue 4, 2004, Pages 297-302

  Takagi, Shigeharu ^a,b   Takahashi, Wakoh ^a,b   Shinohara, Yukito ^a   Yasuda, Seiei ^b   Ide, Michiru ^b   Shohtsu, Akira ^b   Seio, Takahito ^b  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HIMEDIC Imaging Center at Lake Yamanaka   (Japan)

Author keywords

Cerebral metabolic rate of glucose; Input function; PET; Venous sampling

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BRAIN METABOLISM; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; GLUCOSE METABOLISM; HUMAN; MALE; MEASUREMENT; METABOLIC RATE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIOACTIVITY; VENOUS BLOOD;

EID: 4143114474     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02984467     Document Type: Article

References (19)

1. Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol 1979; 6: 371-388.
2. 18F scan in Alzheimer's disease and multi-infarct dementia. Arch Neurol 1983; 40: 711-714.
3. 18F]FDG in the diagnosis of Creutzfeldt-Jakob disease (CJD). J Neurol 2002; 249: 699-705.
4. 2 and CBF by the oxygen-15 inhalation technique. Results in normal volunteers and cerebrovascular patients. Eur Neurol 1981; 20: 285-290.
5. Patronas NJ, DiChiro G, Smith BH, De La Paz R, Brooks RA, Milam HL, et al. Depressed cerebellar glucose metabolism in supratentofial tumors. Brain Res 1984; 291: 93-101.
6. Ohtani T, Kurihara H, Ishiuchi S, Saito N, Oriuchi N, Inoue T, et al. Brain tumour imaging with carbon-11 choline: comparison with FDG PET and gadolinium-enhanced MR imaging. Eur J Nucl Med 2001; 28: 1664-1670.
7. 13N-ammonia. Acta Neurol Scand 1979; 60 (Suppl 72): 538-539.
8. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 1977; 28: 897-916.
9. Correia J. A bloody future for clinical PET? (editorial). J Nucl Med 1992; 32: 620-622.
10. Huang SC, Phelps ME, Hoffman EJ, Sideris K, Selin CJ, Kuhl DE. Noninvasive determination of local cerebral metabolic rate of glucose in man. Am J Physiol 1980; 238: E69-E82.
11. Takikawa S, Dhawan V, Spetsieris P, Robeson W, Chaly T, Dahl R, et al. Noninvasive quantitative fluorodeoxyglucose PET studies with an estimated input function derived from a population-based arterial blood curve. Radiology 1993; 188: 131-136.
12. Wakita K, Imahori Y, Ido T, Fujii R, Horii H, Shimizu M, et al. Simplification for measuring input function of FDG PET: Investigation of 1-point blood sampling method. J Nucl Med 2000; 41: 1484-1490.
13. Bergström M, Litton J, Eriksson L, Bohm C, Blomqvist G. Determination of object contour from projections for attenuation correction in cranial positron emission tomography. J Comput Assist Tomogr 1982; 6: 365-372.
14. Van der Weerdt AP, Klein LJ, Visser CA, Visser FC, Lammertsma AA. Use of arterialized venous instead of arterial blood for measurement of myocardial glucose metabolism during euglycaemic-hyperinsulinaemic clamping. Eur J Nucl Med 2002; 29: 663-669.
15. 11C]glucose for the determination of local cerebral glucose metabolism in humans: variation within and between subjects. J Cereb Blood Flow Met 1982; 2: 307-319.
16. Bartlett EJ, Brodie JD, Wolf AP, Christman DR, Laska E, Meissner M. Reproducibility of cerebral glucose metabolic measurements in resting human subjects. J Cereb Blood Flow Met 1991; 8: 502-512.
17. Vingerhoets FJG, Snow BJ, Schulzer M, Morrison S, Ruth TJ, Holden JE, et al. Reproducibility of fluorine-18-6-fluorodopa positron emission tomography in normal human subjects. J Nucl Med 1994; 35: 18-24.
18. Shinohara Y, Ohnuki Y, Yoshii F, Takahashi W, Onoe K, Takagi S. Detection of primary tumor in paraneoplastic cerebellar degeneration by FDG-PET. Ann Neurol 1998; 43: 684.
19. Ide M, Suzuki Y. Medical health club with clinical PET. Eur J Nucl Med 1996; 23: 1677-1679.